The Dawn of Obesity Centric Medical Practice?

Research on type 2 diabetes mellitus (T2DM) has long highlighted the strong association between body fat and disease development. Despite this, weight loss recommendations remain a standard component of T2DM guidelines. However, a lack of effective tools to address obesity in patients has hindered the implementation of weight loss as a treatment strategy. The advent of Nutrient-Stimulated Hormone (NuSH) based therapies, which can lead to weight loss comparable to surgical interventions, suggests a future where obesity treatments may become the primary approach for managing various conditions related to excess body fat. This shift could lead to the widespread use of anti-obesity medications (AOMs) as a first-line treatment for conditions such as sleep apnea, hypertension, and MASLD. However, significant barriers must be overcome, including dedicated studies to compare obesity-centric approaches to treatment, improved access to these medications, and a better understanding of their safe use in patient-centric obesity care. As evidence accumulates, treatment approaches for non-communicable chronic diseases will likely be significantly altered, with obesity remaining a primary driver of disease worldwide.